S
Stanford Health Care | Stanford Neuroscience Health Center (SNHC)
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
BHV-7000
Platinum
Voriconazole
Isavuconazonium sulfate
Posaconazole
JNJ-81201887
thiazide
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
4 of 13 total trials
The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
Enrolling
Focal Epilepsy
Drug: BHV-7000
Drug: Placebo
The purpose of this study is to evaluate change in geographic atrophy (GA) lesion growth of eyes treated with JNJ-81201887 compared to sham control.
Enrolling
Geographic Atrophy
Drug: Triamcinolone
Other: Sham Procedure
A clinical trial of AAV5-hRKp.RPGR vector for participants with X-linked retinitis pigmentosa (XLRP)
Active, not recruiting
X-Linked Retinitis Pigmentosa
Biological: Genetic: AAV5-hRKp.RPGR Intermediate Dose
Biological: Genetic: AAV5-hRKp.RPGR Low Dose
A clinical trial of AAV5-RPGR vector for participants with X-linked retinitis pigmentosa (XLRP)
Active, not recruiting
X-Linked Retinitis Pigmentosa
Biological: Genetic: AAV5-hRKp.RPGR
Trial sponsors
C
I
V
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems